These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1283770)

  • 21. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should sports activity be encouraged or contraindicated in hypertensive subjects?
    Penco M; Petroni R; Pastori F; Fratini S; Romano S
    J Cardiovasc Med (Hagerstown); 2006 Apr; 7(4):288-95. PubMed ID: 16645404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The metabolic syndrome: common etiology for distinct cardiovascular risk factors?].
    Weisser B; Locher R; Vetter W
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1339-43. PubMed ID: 8272698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15).
    Mohan V; Gokulakrishnan K; Deepa R; Shanthirani CS; Datta M
    Diabet Med; 2005 Sep; 22(9):1206-11. PubMed ID: 16108850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome.
    Hjermann I
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S5-10. PubMed ID: 1283771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
    Andersen P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S29-31. PubMed ID: 1283767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic syndrome].
    Wirth A; Rothenfelde B
    Versicherungsmedizin; 1996 Dec; 48(6):193-9. PubMed ID: 9082643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic abnormalities in hypertension.
    Afonso LC; Edelson GW; Sowers JR
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):219-23. PubMed ID: 9263663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of insulin resistance syndromes.
    Davidson MB
    Am J Med; 1995 Oct; 99(4):420-6. PubMed ID: 7573099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction: the metabolic cardiovascular syndrome.
    Arnesen H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S1-4. PubMed ID: 1283761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance--a secret killer?
    Foster DW
    N Engl J Med; 1989 Mar; 320(11):733-4. PubMed ID: 2646538
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: "Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome".
    Hu FB
    Am J Epidemiol; 2001 Apr; 153(7):717-8. PubMed ID: 11282800
    [No Abstract]   [Full Text] [Related]  

  • 40. Diet, exercise and the metabolic syndrome.
    Pitsavos C; Panagiotakos D; Weinem M; Stefanadis C
    Rev Diabet Stud; 2006; 3(3):118-26. PubMed ID: 17487335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.